Jonathan Bar

9PUBLICATIONS
46CO-AUTHORS
Haematological tumoursEpidemiological methodsLiquid biopsiesMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 27, 2025
OX40 and Regulatory Marker Alterations in Lesional and Non-Lesional Keloid Tissues.

Jonathan Bar, Eden David, Ester Del Duca

|Sep 20, 2024
Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses.

Elena Peeva, Yuji Yamaguchi, Zhan Ye

|Jul 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo.

Yuji Yamaguchi, Elena Peeva, Ester Del Duca

|Aug 22, 2023
Alopecia Areata: Current Treatments and New Directions.

Dante Dahabreh, Seungyeon Jung, Yael Renert-Yuval

Pageof 2